Bayer Stock Up as Government Backs Supreme Court Review in Roundup CaseZacks Investment Research • 12/03/25
RSNA25: Pediatric Study for Bayer's Investigational MRI Contrast Agent Gadoquatrane Meets Primary and Secondary EndpointsBusiness Wire • 12/03/25
Why Bayer Aktiengesellschaft (BAYRY) is a Top Momentum Stock for the Long-TermZacks Investment Research • 12/03/25
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial HyperplasiaBusiness Wire • 12/02/25
Bayer Crop Science Canada Launches EverGol Rise for Enhanced User Experience in Pulse Disease ControlBusiness Wire • 12/02/25
Bayer stock has its best day in 17 years after support from Trump's solicitor generalMarket Watch • 12/02/25
Bayer's MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and PresentationsBusiness Wire • 12/01/25
Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed StudyBenzinga • 11/24/25
Bayer's Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke PreventionBusiness Wire • 11/23/25
BAYRY Obtains Approval for Hormone Free VMS Treatment Lynkuet in the EUZacks Investment Research • 11/19/25
Agricultural Conglomerate Bayer Confident In Long-Term Outlook Despite Litigation RisksBenzinga • 11/12/25